Back to Search
Start Over
Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists
- Source :
- Drugs of today (Barcelona, Spain : 1998). 35(6)
- Publication Year :
- 2003
-
Abstract
- The glycoprotein IIb/IIIa antagonists are potent drugs that inhibit platelet aggregation. They are formulated as monoclonal antibodies and synthetic peptides for intravenous use in patients undergoing high-risk angioplasty procedures and in patients with unstable coronary syndromes. Orally active agents are now being evaluated in clinical trials.
- Subjects :
- Pharmacology
chemistry.chemical_classification
Platelet aggregation
medicine.drug_class
business.industry
medicine.medical_treatment
General Medicine
Monoclonal antibody
Glycoprotein IIb IIIa receptor
Clinical trial
Orally active
chemistry
Angioplasty
medicine
Pharmacology (medical)
In patient
business
Glycoprotein
Subjects
Details
- ISSN :
- 16993993
- Volume :
- 35
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Drugs of today (Barcelona, Spain : 1998)
- Accession number :
- edsair.doi.dedup.....292b9f8d5aa157f3e64a07e907d593cf